Výsledky vyhledávání - "Hitoshi, Miyashita"

Akademický článek

A case of synchronous double cancers consisting of maxillary gingival carcinoma and intraductal papillary mucinous carcinoma, invasive: case report

Autor: Ryosuke Iwama, Hitoshi Miyashita, Atsumu Koketsu, Kiyoshi Kume, Fumiyoshi Fujishima, Atsushi Masamune, Tetsu Takahashi

Publikováno v: BMC Oral Health, Vol 23, Iss 1, Pp 1-6 (2023)

Abstract Background The development of synchronous multiple primary cancers is one of the major causes of death in patients with head and neck cancer. Herein, we report a case of synchronous intraductal papillary mucinous carcinoma (IPMC), invasive i

Externí odkaz: https://doaj.org/article/0b200bf096ce4931a798c478f6e470c8

Zobrazit plný text záznamu

Mandibular osteomyelitis showing remarkable bone resorption in association with Entamoeba gingivalis infection: Report of two cases

Autor: Tsuyoshi Kurobane, Shiro Mori, Hitoshi Miyashita, Hiroyuki Kumamoto, Tetsu Takahashi

Publikováno v: Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 35:143-146

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c209cb9a3ec43ce4a26715cd9e85e6a9
https://doi.org/10.1016/j.ajoms.2022.08.006

Zobrazit plný text záznamu

Glandular odontogenic cyst in mandible: A case report and literature review

Autor: Kensuke Yamauchi, Tetsu Takahashi, Tomonari Kajita, Hiroyuki Kumamoto, Kenji Odashima, Shinnosuke Nogami, Yuta Yanagisawa, Ryosuke Iwama, Hitoshi Miyashita, Jun Kitamura

Publikováno v: Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:531-535

A glandular odontogenic cyst (GOC), a rare type of cyst occurring in the jawbone, comprises about 0.2 % of all odontogenic cyst cases. Recurrence is likely, thus long-term follow-up examinations are necessary. The present patient was a 24-year-old Ja

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc2a7f42bb9a7c63f99ab56e6c54ca26
https://doi.org/10.1016/j.ajoms.2021.11.006

Zobrazit plný text záznamu

Supplementary Figure 1 from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

Autor: Erik Kupperman, Keisuke Kuida, Johnny Yang, Lilly Zhang, Zhe Nie, Sheldon Cao, Takashi Ichikawa, Takashi Sato, Tomohiro Kawamoto, Maki Hasegawa, Noriko Uchiyama, Saomi Murai, Isao Kaieda, Hitoshi Miyashita, Kouki Hikami, Kohei Honda, Yuichi Hikichi

PDF file - 85K, Relationship between TP53 (A) or KRAS (B) gene status and TAK 960 concentration producing EC50 values. Each data point represents a mean concentration producing 50% efficacy (EC50) value for TAK 960 in an individual cell line.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037c5158dd41a6fa50297705386dad3a
https://doi.org/10.1158/1535-7163.22498093

Zobrazit plný text záznamu

Supplementary Figure 2 from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

PDF file - 144K, Comparison of dosing regimens.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674e354c643ecb3506f27cf3520f539f
https://doi.org/10.1158/1535-7163.22498090

Zobrazit plný text záznamu

Supplementary Table 1 from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

PDF file - 61K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be286742458da7f5289a6faab7f0a56
https://doi.org/10.1158/1535-7163.22498081.v1

Zobrazit plný text záznamu

Data from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key processes during mitosis. Human PLK1 has been shown to be overexpressed in various human cancers, and elevated levels of PLK1 have been associated with poor prognosis, mak

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0293f8b92cae4c943434996c1890ddc7
https://doi.org/10.1158/1535-7163.c.6535786

Zobrazit plný text záznamu

Supplementary Figure 3 from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

PDF file - 130K, Anti-tumor activity of TAK-960 in MV4-11luc disseminated leukemia model.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cb82c738efd1b506e891eb7ac6552a
https://doi.org/10.1158/1535-7163.22498084

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání